Staurosporine derivatives for hypereosinophilic syndrome

Details for Australian Patent Application No. 2008201869 (hide)

Owner Novartis AG

Inventors Gilliland, D. Gary; Griffin, James Douglas

Agent Davies Collison Cave

Pub. Number AU-A-2008201869

Parent 2004244747

Filing date 29 April 2008

Wipo publication date 22 May 2008

International Classifications

A61P 7/00 (2006.01) Drugs for disorders of the blood or the extracellular fluid

A61P 11/00 (2006.01) Drugs for disorders of the respiratory system

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

G11B 5/48 (2006.01) Recording by magnetisation or demagnetisation of a record carrier - Disposition or mounting of heads relative to record carriers

Event Publications

15 May 2008 Complete Application Filed

22 May 2008 Application Open to Public Inspection

  Published as AU-A-2008201869

18 December 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008201870-New pharmaceutical uses of Staurosporine derivatives

2008201868-Gaming system and method